Kaia Well being Reduces Again Ache by 46% in Rise-uP Randomized Managed Trial Outcomes

NEW YORK–()–Kaia Well being, the most important international digital therapeutics firm on a mission to make high-quality, evidence-based therapies accessible to anybody, anytime, right this moment introduced outcomes from the Rise-uP randomized managed trial, which demonstrated that the usage of digital multimodal remedy results in a big discount in again ache. After the 12-month trial interval, research members who engaged with the Kaia Well being app skilled a 46% p.c discount in ache and important enhancements in purposeful capability and psychological and bodily high quality of life metrics.

Again ache impacts 8 out of 10 individuals no less than as soon as of their lives1. For these experiencing power low again ache, 85% of problems don’t have any recognized trigger or is non-specific 2.

The research included 1,245 adults with acute, subacute, or recurring non-specific again ache who have been evaluated 4 instances over a 1-year interval.

Individuals got entry to the Kaia Well being app which makes use of a multimodal remedy idea, thought of the gold-standard therapy for again ache. This system combines bodily train, rest, respiration methods, and schooling concerning the causes of ache, weight loss program and life-style modifications, and stress administration.

When in comparison with members within the management group who acquired conventional care, Kaia Well being customers’ ache was decreased by 1.85 factors after solely 3 months and a couple of.55 factors after 12 months on an 11-point numeric ranking scale. Ache discount within the management group was solely 24%. The distinction remained even when controlling for different elements resembling age and ache length.

Individuals within the intervention group additionally skilled important enchancment of their purposeful potential, anxiousness, melancholy, stress, and psychological and bodily high quality of life.

“Because the world’s most clinically validated digital musculoskeletal answer, we’ve got a steadfast dedication to analysis,” in keeping with Nigel Ohrenstein, president of Kaia Well being. “This research additional demonstrates the efficacy in decreasing ache for the tens of millions of people that expertise again ache and improves total high quality of life.”

The research additionally included a cost-effectiveness evaluation that confirmed a discount in healthcare prices of as much as 80% versus conventional care.

As a world firm, it’s a important accomplishment for Kaia Well being to be among the many few digital therapies to be acknowledged by the Federal Joint Committee (G-BA),3 who advisable making use of the strategy of Rise-uP to the usual look after sufferers with nonspecific again ache. Rise-uP is the most important randomized managed trial of a digital well being software and is backed by the German Innovation Fund.

About Kaia Well being

Kaia Well being is the world’s largest digital therapeutics firm that creates accessible, evidence-based therapies for a variety of situations, together with MSK ache and COPD. Kaia Well being covers 60 million lives globally, and its clinically confirmed movement evaluation functionality is remodeling and democratizing healthcare via expertise that sufferers can entry anytime, anyplace, with the digital camera of their smartphone or pill. Kaia Well being is probably the most clinically validated digital MSK supplier, and its movement evaluation expertise is as correct as bodily therapists in suggesting train corrections, leading to equitable care no matter BMI, age, gender, or location. Kaia Well being is a member of the Digital Therapeutics Alliance (DTA) and has workplaces in New York and Munich. Be taught extra at www.kaiahealth.com.


1. Again Ache. MedlinePlus. Accessed July 20, 2022. https://medlineplus.gov/backpain.html

2. O’Sullivan P. Analysis and classification of power low again ache problems: maladaptive motion and motor management impairments as underlying mechanism. Man Ther. 2005;10(4):242-255. doi:10.1016/j.math.2005.07.001

3. Determination of the German Innovation Fund of the Federal Joint Committee. Gemeinsamer Bundesausschuss. Accessed July 29, 2022. https://innovationsfonds.g-ba.de/beschluesse/rise-up-ruecken-innovative-schmerztherapie-mit-e-health-fuer-unsere-patienten.86


Leave a Reply

Your email address will not be published. Required fields are marked *